CTI Cathay International Holdings Ld

TIDMCTI

RNS Number : 6011Z

Cathay International Holdings Ld

16 March 2017

Cathay International Holdings Limited

("Cathay" or the "Company")

Notice of Annual Results 2016

Hong Kong, 16 March 2017 - Cathay International Holdings Limited (LSE: CTI.L), a leading operator and investor in the growing healthcare sector in the People's Republic of China, today announces the Company will issue its Annual Results for the year ended 31 December 2016 on Thursday, 30 March 2017.

-Ends-

For further enquiries, please contact:

 
Cathay International Holdings Limited 
Eric Siu (Finance Director)                    Tel: +852 2828 9289 
 Patrick Sung (Director and Controller) 
 
N+1 Singer 
 Aubrey Powell / Lauren Kettle - Corporate    Tel: +44 (0) 20 7496 
 Finance                                                      3000 
 Brough Ransom - Sales 
 Consilium Strategic Communications 
 Limited 
Mary-Jane Elliott / Matthew Neal /             Tel: +44 (0) 203709 
 Lindsey Neville                                              5708 
 

About Cathay

Cathay International Holdings Limited (LSE: CTI.L) is a main market listed investment holding company and a leading operator and investor in the growing healthcare sector in the People's Republic of China (the "PRC"). The Company and its subsidiaries (collectively the "Group") aim to leverage on growth opportunities in the strong and growing domestic demand for high quality healthcare products in the PRC and build its portfolio companies into market sector leaders with competitive edge. Cathay has already demonstrated a strong track record of identifying high-growth potential investment opportunities in this area including: Lansen, a leading specialty pharmaceutical company focused on rheumatology and dermatology in the PRC; Haizi, a company engaged in the manufacture, marketing and sale of inositol and its by-product, di-calcium phosphate; Natural Dailyhealth, a company engaged in production and sales of plant extracts for use as key active ingredients in healthcare products; and Botai, a company engaged in collagen products.

The Group employs approximately 2,000 people across the PRC, including over 30 specialist corporate and business development staff based at the holding company's offices in Hong Kong and Shenzhen. Cathay also has a hotel investment. For more information please visit the Company's website: www.cathay-intl.com.hk.

This information is provided by RNS

The company news service from the London Stock Exchange

END

NORBLGDXUDBBGRU

(END) Dow Jones Newswires

March 16, 2017 03:01 ET (07:01 GMT)

Cathay International Hol... (LSE:CTI)
Historical Stock Chart
From Apr 2024 to May 2024

Cathay International Hol... (LSE:CTI)
Historical Stock Chart
From May 2023 to May 2024